Ospina Medical and Regenexx
Ospina Medical is the leading practice in New York City for Regenerative Medicine and Interventional Spine and Joint Care. Ospina Medical is also partnered with the biotechnology company Regenexx. Regenexx offers patented PRP injections and SC procedures that act as enhancements of the standard treatments available in the current biotech and medical markets.
Ospina Medical has an approximate 60/40 ratio of patients interested in interventional medicine to patients interested in regenerative medicine. At pain management practices offering a similar array of procedures, this ratio is closer to 75/25. Patients who receive regenerative medicine treatments have their data sent to Regenexx for meta-analyses currently being run on the success of regenerative pain medicine. This is then categorized by body part or region, and improvements to functionality, pain, and overall improvement. The table below contains the condensed, reported rates of success with Regenexx (combined PRP and Stem Cells) in the 1-month, 1-year, and 4-year periods following treatment.